Lidocaine Hci Jelly
Product Images NDC 51662-1389

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Lidocaine Hci (NDC 51662-1389). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Assembly 1 (Assembly 1)

Assembly 1 (Assembly 1)
FDA Label Image

Assembly 2 (Assembly 2)

Assembly 2 (Assembly 2)
FDA Label Image

Assembly 3 (Assembly 3)

Assembly 3 (Assembly 3)
FDA Label Image

How Supplied 1 (How Supplied 1)

How Supplied 1 (How Supplied 1)
This appears to be a product description that includes various sizes and corresponding NDC numbers. The product is not specified so additional information is not available.*
FDA Label Image

How Supplied 2 (How Supplied 2)

How Supplied 2 (How Supplied 2)
This appears to be a label for a pharmaceutical product in a 5 mL size with the given stock number and NDC code. The specific name or type of medication is not included in the text.*
FDA Label Image

Serialized Labeling (Serialized Labeling)

Serialized Labeling (Serialized Labeling)
FDA Label Image

Structure (Structure)

Structure (Structure)
FDA Label Image

Vial Sterile Pak Labeling (Vial Sterile Pak Labeling)

Vial Sterile Pak Labeling (Vial Sterile Pak Labeling)
This is a description of Lidocaine Hydrochloride Jelly USP, 2%. It comes in a 5mL syringe and is for topical use only as a local anesthetic. It is a single-use product with no preservatives added and must be stored at controlled room temperature. Each mL contains 20mg of Lidocaine Hydrochloride and sodium carboxymethylcellulose, and sodium hydroxide may be added to adjust pH. The contents are sterile, and it is important not to open the package until ready to use. The syringe must be assembled using aseptic technique, and the instructions must be followed. This product is made by International Medication Systems, Limited, and it is distributed by Amphastar Pharmaceuticals Company.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.